The Effect of Coleus Forskohlii Extract on the Risk Factors of Metabolic Syndrome

Last updated: May 17, 2014
Sponsor: Olive Lifesciences Pvt Ltd
Overall Status: Trial Status Unknown

Phase

3

Condition

Obesity

High Cholesterol (Hyperlipidemia)

Metabolic Disorders

Treatment

N/A

Clinical Study ID

NCT02143349
ACTRN12614000305628
  • Ages 20-60
  • All Genders

Study Summary

Coleus forskohlii extract contains the bioactive compound, forskolin. Preliminary studies have shown that forskolin can increase fat metabolism thus reduce fat accumulation in both animals and humans. It has been suggested that forskolin may also suppress appetite thus reduce energy intake and results in weight loss. This study will evaluate the appetite suppressant properties of Coleus forskohlii extract. In addition the effect on central obesity and risk factors of metabolic syndrome will also be investigated.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Both Australian males and females, age 20-60 years, Overweight or obese (BMI >25),waist circumference of > 94 cm (male), waist circumference of >80 cm (female)

Exclusion

Exclusion Criteria:

  • Cigarette smoker, hypertension, all types of heart, liver and kidney disease,pregnancy, lactating, Type 1 diabetes and weight loss medication.

Study Design

Total Participants: 50
Study Start date:
April 01, 2014
Estimated Completion Date:
May 31, 2015

Connect with a study center

  • College of Health and Biomedicine Victoria University

    St. Albans, Victoria 14428
    Australia

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.